Literature DB >> 17926208

Access for the terminally ill to experimental medical innovations: a three-pronged threat.

Shira Bender1, Lauren Flicker, Rosamond Rhodes.   

Abstract

Mesh:

Substances:

Year:  2007        PMID: 17926208     DOI: 10.1080/15265160701672255

Source DB:  PubMed          Journal:  Am J Bioeth        ISSN: 1526-5161            Impact factor:   11.229


× No keyword cloud information.
  5 in total

1.  Innovative Practice, Clinical Research, and the Ethical Advancement of Medicine.

Authors:  Jake Earl
Journal:  Am J Bioeth       Date:  2019-06       Impact factor: 11.229

2.  Conceptualising Surgical Innovation: An Eliminativist Proposal.

Authors:  Giles Birchley; Jonathan Ives; Richard Huxtable; Jane Blazeby
Journal:  Health Care Anal       Date:  2020-03

Review 3.  At the cross-roads of participatory research and biomarker discovery in autism: the need for empirical data.

Authors:  Afiqah Yusuf; Mayada Elsabbagh
Journal:  BMC Med Ethics       Date:  2015-12-15       Impact factor: 2.652

4.  Expanded Access Programs: Ethical and Practical Considerations for Biopharmaceutical Sponsors.

Authors:  Mitchell Klopfenstein; Luann E Van Campen; Timothy Garnett
Journal:  Ther Innov Regul Sci       Date:  2015-04-02       Impact factor: 1.778

5.  Charlie Gard and the weight of parental rights to seek experimental treatment.

Authors:  Giles Birchley
Journal:  J Med Ethics       Date:  2018-05-17       Impact factor: 5.926

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.